Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): C Noah Nilsson , Mads Kristian Ersbøll , Finn Gustafsson Added: 8 months ago

Heart Failure
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more

Heart Failure

Prevention & Chronic Conditions
An Expert Approach to Cardio-Renal Protection in CKD: Part One
Author(s): Navdeep Tangri , James Burton , David Wheeler Added: 1 year ago
Part one of this two-part programme focuses on our current guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK), Dr Navdeep Tangri (University of… View more

Heart Failure

Prevention & Chronic Conditions
Kevin Damman
Research Area(s) / Expertise:

Heart Failure

Imaging & Diagnostics

 Job title: Head of the Heart Transplant and Left Ventricular Device Program
Dr Kevin Damman is Head of the Heart Transplant and Left Ventricular Device Program at the University Medical Center Groningen in the Netherlands. His research interests focus on acute and advanced heart failure, including cardiorenal axis. He is also interested in improving the treatment of acute heart failure patients, with early assessment of decongestive therapies, SGLT2 inhibitors in… View more
2023 ESC Guidelines Update: Acute & Chronic Heart Failure
Author(s): Giuseppe Rosano , Harriette Van Spall Added: 1 year ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Prof Rosano summarises the retained ejection fraction… View more

Guidelines & Statements

Heart Failure
ESC – Heart Failure Guideline Review
Author(s): Carolyn Lam , Giuseppe Rosano Added: 1 year ago
In this short video series, recorded at ESC 2023 in Amsterdam,Prof Carolyn Lam(National Heart Centre Singapore, SG) and Prof Giuseppe Rosano(St George’s University Medical School of London, UK) discuss the latest heart failure guideline updates and what this means for clinical practice. Since the publication of the 2021 ESC Guidelines, several randomised controlled trials have provided… View more

Guidelines & Statements

Heart Failure
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 6 months ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
An Expert Approach to Cardio-Renal Protection in CKD: Part Two
Author(s): James Burton Added: 1 year ago
Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK) and Dr Navdeep Tangri (University of Manitoba, CA).Dr Tangri begins by providing an overview of the recent KDIGO guideline updates. Following this, the panel recap on the patient case that was presented in part one of… View more

Heart Failure

Prevention & Chronic Conditions
ESC 24 Hot Line Discussion: The FINEARTS-HF Trial
Author(s): Harriette Van Spall , Scott Solomon Added: 8 months ago
ESC Congress 2024 — FINEARTS-HF shows finerenone reduces cardiovascular death and total of worsening heart failure (HF) events over median follow-up of 32 months.Host, Dr Harriette Van Spall (McMaster University, CA) is joined by Principal investigator, Dr Scott Solomon (Brigham And Women's Hospital & Harvard Medical School, US) to discuss findings from the landmark FINEARTS-HF trial (NCT04435626… View more

Heart Failure
ACC 24 Late-Breaker Discussion: The EMPACT-MI Trial
Author(s): Harriette Van Spall , Javed Butler Added: 1 year ago
ACC.24 — Join Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA), and Principal Investigator, Dr Javed Butler (University of Mississippi Medical Center, US), as they discuss the key findings from the EMPACT-MI trial (Boehringer Ingelheim)(NCT04509674).In this multicentre, randomised, parallel group, double-blind placebo-controlled superiority trial, investigators evaluated the… View more

Heart Failure

MI/ACS